206 related articles for article (PubMed ID: 29768356)
1. Late distant recurrence of breast carcinoma and metastasis to the main bronchus and choroid: A case report.
Luo Z; Cai Q; Zhao Y; Wang X; Fu S; Zhai L
Medicine (Baltimore); 2018 May; 97(20):e10754. PubMed ID: 29768356
[TBL] [Abstract][Full Text] [Related]
2. Choroidal and optic disc metastases from breast cancer and their response to combination pharmacotherapy with tamoxifen, cyclophosphamide hydrate, letrozole, and bevacizumab.
Zako M; Takeyama M; Naito E; Mizumoto K; Iwaki M
J Ocul Pharmacol Ther; 2012 Feb; 28(1):89-93. PubMed ID: 22011078
[TBL] [Abstract][Full Text] [Related]
3. Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.
Colleoni M; Luo W; Karlsson P; Chirgwin J; Aebi S; Jerusalem G; Neven P; Hitre E; Graas MP; Simoncini E; Kamby C; Thompson A; Loibl S; Gavilá J; Kuroi K; Marth C; Müller B; O'Reilly S; Di Lauro V; Gombos A; Ruhstaller T; Burstein H; Ribi K; Bernhard J; Viale G; Maibach R; Rabaglio-Poretti M; Gelber RD; Coates AS; Di Leo A; Regan MM; Goldhirsch A;
Lancet Oncol; 2018 Jan; 19(1):127-138. PubMed ID: 29158011
[TBL] [Abstract][Full Text] [Related]
4. Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05).
Blok EJ; Kroep JR; Meershoek-Klein Kranenbarg E; Duijm-de Carpentier M; Putter H; van den Bosch J; Maartense E; van Leeuwen-Stok AE; Liefers GJ; Nortier JWR; Rutgers EJT; van de Velde CJH;
J Natl Cancer Inst; 2018 Jan; 110(1):. PubMed ID: 28922787
[TBL] [Abstract][Full Text] [Related]
5. Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial.
Zdenkowski N; Forbes JF; Boyle FM; Kannourakis G; Gill PG; Bayliss E; Saunders C; Della-Fiorentina S; Kling N; Campbell I; Mann GB; Coates AS; Gebski V; Davies L; Thornton R; Reaby L; Cuzick J; Green M;
Ann Oncol; 2016 May; 27(5):806-12. PubMed ID: 26861603
[TBL] [Abstract][Full Text] [Related]
6. Prediction of late disease recurrence and extended adjuvant letrozole benefit by the HOXB13/IL17BR biomarker.
Sgroi DC; Carney E; Zarrella E; Steffel L; Binns SN; Finkelstein DM; Szymonifka J; Bhan AK; Shepherd LE; Zhang Y; Schnabel CA; Erlander MG; Ingle JN; Porter P; Muss HB; Pritchard KI; Tu D; Rimm DL; Goss PE
J Natl Cancer Inst; 2013 Jul; 105(14):1036-42. PubMed ID: 23812955
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant letrozole in postmenopausal estrogen and/or progesterone receptor positive breast cancer: a phase IIb/III trial to investigate optimal duration of preoperative endocrine therapy.
Krainick-Strobel UE; Lichtenegger W; Wallwiener D; Tulusan AH; Jänicke F; Bastert G; Kiesel L; Wackwitz B; Paepke S
BMC Cancer; 2008 Feb; 8():62. PubMed ID: 18302747
[TBL] [Abstract][Full Text] [Related]
8. A case of prolonged disease-free survival in a patient with choroidal metastasis from breast cancer.
Jang RW; Doherty M; Hopkins JJ; Warner E
Nat Clin Pract Oncol; 2009 Feb; 6(2):118-21. PubMed ID: 19065141
[TBL] [Abstract][Full Text] [Related]
9. Management of choroidal metastases from breast carcinomas using aromatase inhibitors.
Manquez ME; Brown MM; Shields CL; Shields JA
Curr Opin Ophthalmol; 2006 Jun; 17(3):251-6. PubMed ID: 16794437
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.
Goss PE; Ingle JN; Martino S; Robert NJ; Muss HB; Piccart MJ; Castiglione M; Tu D; Shepherd LE; Pritchard KI; Livingston RB; Davidson NE; Norton L; Perez EA; Abrams JS; Cameron DA; Palmer MJ; Pater JL
J Natl Cancer Inst; 2005 Sep; 97(17):1262-71. PubMed ID: 16145047
[TBL] [Abstract][Full Text] [Related]
11. Extended breast cancer treatment with an aromatase inhibitor (Letrozole) after tamoxifen: why, who and how long?
Kaufmann M; Rody A
Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):146-54. PubMed ID: 16621229
[TBL] [Abstract][Full Text] [Related]
12. Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.
Regan MM; Neven P; Giobbie-Hurder A; Goldhirsch A; Ejlertsen B; Mauriac L; Forbes JF; Smith I; Láng I; Wardley A; Rabaglio M; Price KN; Gelber RD; Coates AS; Thürlimann B; ;
Lancet Oncol; 2011 Nov; 12(12):1101-8. PubMed ID: 22018631
[TBL] [Abstract][Full Text] [Related]
13. Regression of choroidal metastasis from a carcinoma of the male breast: case report.
Paoli D
Ophthalmologica; 1998; 212 Suppl 1():74-6. PubMed ID: 9730758
[TBL] [Abstract][Full Text] [Related]
14. Regression of choroidal metastasis from breast carcinoma following Letrozole therapy.
Venkatesh P; Garg S
Clin Exp Ophthalmol; 2007 Jul; 35(5):492-4. PubMed ID: 17651258
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy study of 5-year letrozole or anastrozole in postmenopausal hormone receptor-positive early breast cancer.
Sendur MA; Aksoy S; Zengin N; Altundag K
J BUON; 2013; 18(4):838-44. PubMed ID: 24344006
[TBL] [Abstract][Full Text] [Related]
16. Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.
Jakesz R; Greil R; Gnant M; Schmid M; Kwasny W; Kubista E; Mlineritsch B; Tausch C; Stierer M; Hofbauer F; Renner K; Dadak C; Rücklinger E; Samonigg H;
J Natl Cancer Inst; 2007 Dec; 99(24):1845-53. PubMed ID: 18073378
[TBL] [Abstract][Full Text] [Related]
17. Letrozole in the neoadjuvant setting: the P024 trial.
Ellis MJ; Ma C
Breast Cancer Res Treat; 2007; 105 Suppl 1(Suppl 1):33-43. PubMed ID: 17912634
[TBL] [Abstract][Full Text] [Related]
18. Choroid as the first recurrence site: 13 years after breast carcinoma.
Liu T; Xu Y; Wan L; Yu B
J Cancer Res Ther; 2012; 8(4):639-40. PubMed ID: 23361289
[TBL] [Abstract][Full Text] [Related]
19. SIMULTANEOUS CHOROIDAL AND RETINAL METASTASES FROM LUNG CARCINOMA.
Jorge DM; Labarrere M; Rodrigues MW; Shields CL; Jorge R
Retin Cases Brief Rep; 2020; 14(1):90-95. PubMed ID: 28850049
[TBL] [Abstract][Full Text] [Related]
20. Unusual Case of Papillary Thyroid Carcinoma with Choroidal Metastasis.
Makhija C; Su YB; Goldner W
Thyroid; 2015 Jul; 25(7):860-4. PubMed ID: 25872533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
